Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides

NAActive, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 2, 2022

Primary Completion Date

September 10, 2027

Study Completion Date

September 10, 2027

Conditions
HIVInfant MorbidityBreast Feeding
Interventions
DIETARY_SUPPLEMENT

Synbiotic

Synbiotic (2'-FL HMO + B. infantis probiotics)

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin

Trial Locations (1)

7599

Worcester Campus of Stellenbosch University (SU), Stellenbosch

All Listed Sponsors
collaborator

University of Stellenbosch

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Columbia University

OTHER